Table 1 Patient characteristics
Glycerol 200 mL/30 min | Glycerol 200 mL/60 min | Mannitol 300 mL/60 min | P value | |
|---|---|---|---|---|
n = 13 | n = 13 | n = 7 | ||
Age, years | 57 (47–66) | 46 (38–69) | 58 (45–62) | 0.592 |
Male, sex | 6 (46.1%) | 5 (38.5%) | 4 (57.2%) | 0.724 |
Height, cm | 161 (154–166) | 155 (154–164) | 170 (155–170) | 0.229 |
Body weight, kg | 60 (51–65) | 60 (55–69) | 62 (54–67) | 0.731 |
Body mass index, kg/m2 | 23.9 (19.4–25.7) | 25.0 (21.2–26.9) | 21.7 (21.1–27.9) | 0.573 |
Diseases, % | 0.426 | |||
Brain tumor | 7.7% | 23.1% | 0.0% | |
Intracranial hemorrhage | 15.4% | 23.1% | 14.3% | |
Sub-arachnoid hemorrhage | 23.1% | 7.7% | 42.9% | |
Cerebral infarction | 38.5% | 38.5% | 28.6% | |
Traumatic brain injury | 0.0% | 7.7% | 14.3% | |
Other | 15.4% | 0.0% | 0.0% | |
IHD | 7.7% | 0.0% | 0.0% | 0.452 |
CHF | 0.0% | 15.4% | 0.0% | 0.194 |
Atrial fibrillation | 15.4% | 15.4% | 0.0% | 0.542 |
Diabetes mellitus | 15.4% | 23.1% | 14.3% | 0.840 |
Hypertension | 30.8% | 23.1% | 42.9% | 0.655 |
APACHE II | 19 (13–22) | 16 (13–28) | 18 (11–22) | 0.858 |
28-day survival, % | 69.2% | 100.0% | 100.0% | 0.030 |